Belpointe Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Belpointe Asset Management LLC

$1.28 Billion
Q2 2024

A detailed history of Belpointe Asset Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Belpointe Asset Management LLC holds 1,789 shares of REGN stock, worth $1.88 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,789

Previous 1,314 36.15%

Holding current value

$1.88 Million

Previous $1.26 Million 48.73%

% of portfolio

0.15%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$883.2 - $1071.19 $419,520 - $508,815	475 Added 36.15%	1,789 $1.88 Million
Q1 2024 May 08, 2024	BUY	$902.69 - $993.35 $889,149 - $978,449	985 Added 299.39%	1,314 $1.26 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $374,411 - $425,861	-483 Reduced 59.48%	329 $288,000
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $303,985 - $370,678	439 Added 117.69%	812 $668,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $468,320 - $555,504	-669 Reduced 64.2%	373 $268,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $41,509 - $50,445	-61 Reduced 5.53%	1,042 $856,000
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $105,883 - $114,958	-150 Reduced 11.97%	1,103 $795,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $346,677 - $437,489	604 Added 93.07%	1,253 $863,000
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $2,193 - $2,955	-4 Reduced 0.61%	649 $384,000
Q1 2022 Apr 28, 2022	SELL	$595.12 - $698.43 $667,724 - $783,638	-1,122 Reduced 63.21%	653 $456,000
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $1.92 Million - $2.37 Million	-3,525 Reduced 66.51%	1,775 $1.12 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1.63 Million - $1.94 Million	2,842 Added 115.62%	5,300 $3.21 Million
Q2 2021 Aug 09, 2021	SELL	$472.8 - $558.54 $965,930 - $1.14 Million	-2,043 Reduced 45.39%	2,458 $1.37 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $1.82 Million - $2.24 Million	4,080 Added 969.12%	4,501 $1.93 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $956 - $1,215	2 Added 0.48%	421 $203,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $8,171 - $9,873	15 Added 1.44%	1,058 $517,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $348,095 - $420,596	-639 Reduced 60.4%	419 $235,000
Q2 2020 Jul 20, 2020	SELL	$493.32 - $643.92 $7,399 - $9,658	-15 Reduced 1.42%	1,043 $650,000
Q1 2020 Jul 20, 2020	SELL	$336.18 - $494.43 $163,383 - $240,292	-486 Reduced 31.48%	1,058 $517,000
Q4 2019 Feb 18, 2020	BUY	$274.13 - $376.51 $423,256 - $581,331	1,544 New	1,544 $580,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History